CSafe experts will be on hand to demonstrate the company’s Cell & Gene thermal shipping solution at the Phacilitate Leaders World conference in Miami. The CSafe Cell & Gene thermal shipping solution leverages the company’s industry-leading temperature management performance for the safe transport.
The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.This designation highlights the GW Cancer Center’s growing regional and global reputation for treating patients with advanced squamous cell carcinoma.
